-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Friday's After-Market Session
Share
Listen to the news

Gainers

  • InspireMD (NASDAQ:NSPR) shares rose 25.2% to $1.44 during Friday's after-market session. The market value of their outstanding shares is at $55.2 million.
  • Celularity (NASDAQ:CELU) shares moved upwards by 22.25% to $1.17. The market value of their outstanding shares is at $26.6 million. As per the press release, Q4 earnings came out yesterday.
  • Indaptus Therapeutics (NASDAQ:INDP) shares increased by 12.14% to $2.4. The company's market cap stands at $6.2 million.
  • Bluejay Diagnostics (NASDAQ:BJDX) shares rose 7.55% to $2.06. The company's market cap stands at $1.8 million.
  • BioVie (NASDAQ:BIVI) shares moved upwards by 4.16% to $1.75. The market value of their outstanding shares is at $12.4 million.
  • Kairos Pharma (AMEX:KAPA) stock rose 4.05% to $0.59. The market value of their outstanding shares is at $12.0 million.

Losers

  • Akanda (NASDAQ:AKAN) stock fell 9.8% to $51.5 during Friday's after-market session. The market value of their outstanding shares is at $26.1 million.
  • TELA Bio (NASDAQ:TELA) stock declined by 7.84% to $0.91. The market value of their outstanding shares is at $39.1 million.
  • WORK Medical Tech Gr (NASDAQ:WOK) shares fell 7.76% to $1.19.
  • Scilex Holding (NASDAQ:SCLX) stock decreased by 7.19% to $9.82. The company's market cap stands at $73.9 million.
  • Sangamo Therapeutics (NASDAQ:SGMO) stock fell 6.6% to $0.13. The company's market cap stands at $44.3 million.
  • Cue Biopharma (NASDAQ:CUE) stock decreased by 6.32% to $28.5. The company's market cap stands at $47.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending